Search Results - S. V. Glagolev

Monitoring of drug safety by B. K. Romanov, S. V. Glagolev, V. A. Polivanov, M. V. Leonova

Connect to this object online.

Hospital consumption of direct oral anticoagulants in regions of the Russian Federation in 2017-2022 by A. V. Matveev, S. V. Glagolev, K. N. Koryanova, D. A. Sychev

Connect to this object online.

Typical pharmacovigilance system master file (PSMF) by B. K. Romanov, R. N. Alyautdin, S. V. Glagolev, V. A. Polivanov

Connect to this object online.

Guidelines for the Preparation of a Document Containing the Drug Safety Monitoring Results by Yu. V. Olefir, B. K. Romanov, R. N. Alyautdin, S. V. Glagolev

Connect to this object online.

Guidelines for the planning and implementation of pharmacovigilance systems audit by S. V. Glagolev, Yu. V. Olefir, B. K. Romanov, R. N. Alyautdin

Connect to this object online.

Systemic characteristic of safety profile of monoclonal antibodies used in rheumatology practice by A. V. Philippova, A. S. Kolbin, E. V. Verbitskaya, S. V. Glagolev, V. A. Polivanov

Connect to this object online.

Standard form of a periodic safety update report by B. R. Romanov, R. N. Alyautdin, M. A. Darmostukova, S. V. Glagolev, V. A. Polivanov

Connect to this object online.

Preparation of a periodic safety update report by B. K. Romanov, R. N. Alyautdin, S. V. Glagolev, V. A. Polivanov, A. E. Krasheninnikov

Connect to this object online.

Perfection of management principles by the safety signals of medicinal products by B. K. Romanov, V. K. Lepakhin, E. O. Zhuravleva, A. V. Astakhova, S. V. Glagolev, V. A. Polivanov

Connect to this object online.

Safety issues of monoclonal antibodies used in rheumatology by A. V. Philippova, A. S. Kolbin, E. V. Verbitskaya, S. V. Glagolev, V. A. Polivanov, V. I. Mazurov, R. R. Samigullina

Connect to this object online.

Pharmacogenetics and pharmacokinetics of rivaroxaban in patients with atrial fibrillation and chronic kidney disease by N. A. Shatalova, D. A. Sychev, K. B. Mirzaev, A. I. Kochetkov, E. Yu. Ebzeeva, V. B. Dashabylova, P. O. Bochkov, S. N. Tuchkova, S. V. Glagolev

Connect to this object online.

ON THE ISSUE OF SAFETY OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS by N. Yu. Velts, T. M. Bukatina, E. O. Zhuravleva, G. V. Kutekhova, M. A. Darmostukova, Yu. V. Olefir, B. K. Romanov, S. V. Glagolev, V. A. Polivanov

Connect to this object online.

Analysis of spontaneous reports of adverse reactions, developed in the use of drugs during pregnancy by E. O. Zhuravleva, N. Yu. Velts, K. E. Zatolochina, S. V. Glagolev, V. A. Polivanov, M. A. Darmostukova, V. K. Lepakhin, B. K. Romanov, R. N. Alyautdin

Connect to this object online.

Effect of CYP3A4/5, ABCB1 gene polymorphisms on the residual equilibrium concentration of apixaban and bleeding in patients with non-valvular atrial fibrillation and deep vein thro... by l. V. Fedina, i. N. Sychev, K. V. Mirzaev, A. V. Vardanyan, S. V. Glagolev, A. A. Kachanova, P. O. Bochkov, R. V. Shevchenko, S. N. Tuchkova, I. V. Sychev, S. P. Abdullaev, D A. Sychev

Connect to this object online.

Safety of Pharmacotherapy in COVID-19 Patients: A Literature Review by A. V. Kryukov, A. S. Zhiryakova, Yu. V. Shevchuk, A. V. Matveev, V. I. Vechorko, O. V. Averkov, S. V. Glagolev, I. I. Temirbulatov, K. B. Mirzaev, N. P. Denisenko, Sh. P. Abdullaev, D. A. Sychev

Connect to this object online.

Drug Safety for Children - International Monitoring Data for 50 Years by B. K. Romanov, Yu. V. Olefir, R. N. Alyautdin, S. V. Glagolev, V. A. Polivanov, L. I. Ilienko, S. P. Alpatov, N. V. Bogush, N. M. Buyanova, I. V. Ganshina, G. O. Dibirova, N. B. Dmitrieva, I. B. Zhukova, E. V. Kalinina, A. V. Kirillova, N. M. Kiseleva, G. V. Kukushkin, T. I. Leonteva, M. L. Maximov, E. V. Markina, S. E. Mileshina, D. E. Yurov

Connect to this object online.